Form 8-K - Current report:
SEC Accession No. 0001193125-24-248761
Filing Date
2024-10-31
Accepted
2024-10-31 16:48:00
Documents
18
Period of Report
2024-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d904376d8k.htm   iXBRL 8-K 31983
2 EX-1.1 d904376dex11.htm EX-1.1 180070
3 EX-5.1 d904376dex51.htm EX-5.1 8361
4 EX-99.1 d904376dex991.htm EX-99.1 8401
8 GRAPHIC g904376g1031073736796.jpg GRAPHIC 2537
9 GRAPHIC g904376g1031204456979.jpg GRAPHIC 4788
  Complete submission text file 0001193125-24-248761.txt   421643

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA calc-20241030.xsd EX-101.SCH 2522
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE calc-20241030_lab.xml EX-101.LAB 17948
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE calc-20241030_pre.xml EX-101.PRE 11243
21 EXTRACTED XBRL INSTANCE DOCUMENT d904376d8k_htm.xml XML 3772
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 241415871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)